W. Whaley

Recombination events suggest potential sites for the Huntington's disease gene

A. Poustka, J. Haines, M. Bucan, 1989, Neuron.

Mapping of D4S98/S114/S113 confines the Huntington's defect to a reduced physical region at the telomere of chromosome 4.

J. Haines, M. Bucan, M. MacDonald, 1988, Nucleic acids research.

A yeast artificial chromosome telomere clone spanning a possible location of the Huntington disease gene.

M. MacDonald, J. Gusella, S. Baxendale, 1990, American journal of human genetics.

Physical maps of 4p16.3, the area expected to contain the Huntington disease mutation.

M. Bucan, M. MacDonald, T. Pohl, 1990, Genomics.

Defined physical limits of the Huntington disease gene candidate region.

H. Lehrach, J. Gusella, S. Baxendale, 1991, American journal of human genetics.

A DNA segment encoding two genes very tightly linked to Huntington's disease.

J. Haines, M. Bucan, M. MacDonald, 1987, Science.

Increased recombination adjacent to the Huntington disease-linked D4S10 marker.

M. Bucan, M. MacDonald, N. Wexler, 1991, Genomics.

Complex patterns of linkage disequilibrium in the Huntington disease region.

M. MacDonald, H. Lehrach, J. Gusella, 1991, American journal of human genetics.

Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo.

H. Garewal, R. Navari, S. Madajewicz, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

De novo expansion of a (CAG)n repeat in sporadic Huntington's disease

J. Gusella, W. Koroshetz, J. Vonsattel, 1993, Nature genetics.